Genotype-phenotype correlations in peroxisomal disorders

Developmental Brain Dysfunction

Volumn 10, Issue 5, 1997, Pages 282-292

  Moser, Hugo W ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adrenoleukodystrophy; Genotype; Peroxisomes; Refsum disease; Rhizomelic chondrodysplasia punctata; Zellweger syndrome

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; OXIDOREDUCTASE; PLASMALOGEN;

ADRENOLEUKODYSTROPHY; ARTICLE; BRAIN DYSFUNCTION; CHONDRODYSPLASIA PUNCTATA; CLINICAL FEATURE; CORRELATION FUNCTION; GENOTYPE; HUMAN; HYPEROXALURIA; MENTAL DEFICIENCY; PHENOTYPE; REFSUM DISEASE; ZELLWEGER SYNDROME;

EID: 0031544655     PISSN: 10195815     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Moser HW: Peroxisomal diseases; in Barnes LAE (ed): Advances in Pediatrics, vol 36. Chicago, Year Book Medical Publishers, 1989, pp 1-38.
2. Moser HW: Peroxisomal diseases; in Harris H, Hirschhorn KE (eds): Advances in Human Genetics, vol 31. New York, Plenum, 1993, pp 1-106.
3. Lazarow PB, Moser HW: Disorders of peroxisomal biogenesis; in Scriver CR, Beaudet AL, Sly WS, Valle DE (eds): The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 199, pp 2287-2324.
4. Fournier B, Smeitink AM, Dorland L, Berger R, Saudubray LJM, Poll-The BT: Peroxisomal disorders: A review. J Inherit Metab Dis 1994;17: 470-486.
5. Moser HW, Smith KD, Moser AB: X-linked adrenoleukodystrophy; in Scriver CR, Beaudet AL, Sly WS, Valle DE (eds): The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1994, pp 2325-2349.
6. Purdue PE, Takada T, Danpure CJ: Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol 1990;111:2341-2351.
7. Steinberg D: Refsum disease; in Scriver CR, Beaudet AL, Sly WS, Valle DE (eds): The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1994, pp 2351-2369.
8. Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, Hajra AK, Chen G, Raymond G, Liu A, Gordon D, Garnaas K, Walton DS, Skjeldal OH, Guggenheim MA, Jackson LG, Elias ER, Moser HW: Phenotype of patients with peroxisomal disorders subdivided into 16 complementation groups. J Pediatr 1995;127:13-22.
9. Theil AC, Schutgens RBH, Wanders RJA, Heymans HSA: Clinical recognition of patients affected by a peroxisomal disorder: A retrospective study in 40 patients. Eur J Pediatr 1992;151: 117-120.
10. Moser HW: Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain 1997: 120:1485-1508.
11. Wanders RJA, Barth PG, Schutgens RBH, Heymans HSA: Peroxisomal disorders: Post and prenatal diagnosis based on a new classification with flowcharts. Int Pediatr 1996;11:203-214.
12. Danpure CJ, Purdue PE: Primary hyperoxaluria in the cellular level; in Scriver CR, Beaudet AL, Sly WS, Valle DE (eds): The Metabolic Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1994, pp 2385-2424.
13. Krivit W, Lockman LA, Watkins PA, Hirsch J, Shapiro EG: The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. J Inherit Metab Dis 1995;18:398-412.
14. Martinez M, Mougan I, Roig M, Ballabriga A: Blood polyunsaturated fatty acids in patients with peroxisomal disorders: A multicenter study. Lipids 1994:29:273-280.
15. Martinez M, Pineda M, Vidai R, Martin B: Docosahexaenoic acid: A new therapeutic approach to peroxisomal patients. Experience with two cases. Neurology 1993:43:1389-1397.
16. Odone A, Odone M: Lorenzo's oil: A new treatment for adrenoleukodystrophy. J Pediatr Neurosci 1989;5:55-61.
17. Rizzo WB, Leshner RT, Odone A, Dammann AL, Craft DA, Jensone ME, Jennings SS, Davis S, Jaitly R, Sgro JA: Dietary erucic acid therapy for X-linked adrenoleukodystrophy. Neurology 1989;39: 1415-1422.
18. Poulos AS, Christodoulou J, Chow CW, Goldblatt J, Paton BC, Suzuko Y, Shimozawa N: Peroxisomal assembly defects: Clinical, pathologic, and biochemical findings in two patients in a newly identified complementation group. J Pediatr 1995; 127:596-599.
19. Distel B, Erdmann R, Gould SJ, Blobel G, Crane DI, Cregg JM, Dodt G, Fujiki Y, Goodman JM, Just WW, et al.: A unified nomenclature for peroxisome biogenesis factors. J Cell Biol 1996;133: 1-3.
20. Braverman N, Dodt G, Gould SJ, Valle D: Disorders of peroxisome biogenesis. Hum Mol Genet 1995;4:1791-1798.
21. Yahraus T, Braverman N, Dodt G, Kalish JE, Morrell C, Moser HW, Valle D, Gould SJ: The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for the stability of the PTS1 receptor. EMBO J 1996;15:2914-2923.
22. Dodd A, Rowland SA, Hawkes SLJ, Kennedy MA, Love DR: Mutations in the adrenoleukodystrophy gene. Hum Mutat 1997:9:500-511.
23. Berger J, Molzer B, Fae I, Bernheimer H: X-linked adrenoleukodystrophy (ALD): A novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes. Biochem Biophys Res Commun 1994;205:1638-1643.
24. Maestri NE, Beaty TH: Predictions of a 2-locus model for disease heterogeneity: Application to adrenoleukodystrophy. Am J Med Genet 1992;44: 576-582.
25. Moser HW, Moser AB, Smith KD, Bergin A, Borel J, Shankroff J, Stine OC, Merette C, Ott J, Krivit W, Shapiro E: Adrenoleukodystrophy: Phenotypic variability: Implications for therapy. J Inherit Metab Dis 1992;15:645-664.
26. Sobue G, Ueno-Natsukari I, Okamoto H, Connell TA, Aizawa I, Mizoguchi K, Honma M, Ishiwaka G, Mitsuma T, Natsukari N: Phenotypic heterogeneity of an adult form of adrenoleukodystrophy in monozygotic twins. Ann Neurol 1994; 36:912-915.
27. Korenke GC, Fuchs S, Krasemann E, Doerr HG, Wilichowski E, Hunneman DH, Hanefeld F: Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype. Ann Neurol 1996;40:254-257.
28. Wilkinson IA, Hopkins IJ, Pollard AC: Can head iniury influence the site of demyelination in adrenoleukodystrophy. Dev Med Child Neurol 1987;29:784-804.
29. Watkins PA, McGuinness MC, Raymond GV, Hicks BA, Sisk JM, Moser AB, Moser HW: Distinction between peroxisomal bifunctional enzyme and acyl-CoA. Ann Neurol 1995; 38: 472-477.
30. Kaufmann WE, Theda C, Naidu S, Moser AB, Moser HW: Zellweger-like neuronal migration abnormality in a patient with an isolated defect of peroxisomal fatty acid oxidation. Ann Neurol 1991;30:497a-498a.
31. Wanders RJA, Denis S, Wouters F, Wirtz KWA, Seedor U: Sterol carrier protein X (SCPx) is a peroxisomal branched-chain beta-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: A new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes. Biochem Biophys Res Commun 1997;236:565-569.
32. Goldfischer S, Collins J, Rapin I, Neumann P, Neglia W, Spiro AJ, Ishii T, Roels F, Vamecq J, Van Hoof F: Pseudo-Zellweger syndrome: Deficiencies in several peroxisomal oxidative activities. J Pediatr 1986;108: 25-32.
33. Wanders RJA, Schumacher H, Heikoop J, Schutgens RBH, Tager JM: Human dihydroxyacetone-phosphate acyltransferase deficiency: A new peroxisomal disorder. J Inherit Merab Dis 1992;15: 389-391.
34. Wanders RJA, Dekker C, Hovarth VAP, Schutgens RBH, Tager JM, Van Laer P, Lecoutere D: Human alkyldihydroxyacetonephosphate synthase deficiency: A new peroxisomal disorder. J Inherit Metab Dis 1994;17:315-318.
35. Clayton PT, Eckhardt S, Wilson J, Hall CM, Yousuf Y, Wanders RJA, Schutgens RBH: Isolated dihydroxyacetonephosphate acyltransferase deficiency presenting with developmental delay. J Inherit Metab Dis 1994;17:533-540.
36. Jansen GA, Wanders RJA, Watkins PA, Mihalik SJ: Phtanoyl-coenzyme A hydroxylase deficiency - The enzyme defect in Refsum's disease. N Engl J Med 1997;337:133-134.
37. Mihalik SJ, Morell SJ, Kim D, Watkins PA, Gould SJ: Identification of PAHX, a Refsum disease gene. Nat Genet, in press.
38. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, Fransen M, Evrard P, Fahimi D, Declercq PE, Collen D, Van Veldhoven PP, Mannaerts GP: A mouse model for Zellweger syndrome. Nat Genet 1997; 17:49-57.
39. Lu J-F, Lawler AM, Watkins PA, Powers JM, Moser AB, Moser HW, Smith KD: A mouse model for X-linked adrenoleukodystrophy. Proc Natl Acad Sci USA 1997;94:9366-9371.
40. Kobayashi T, Shinnoh N, Kondo A, Tamada T: Adrenoleukodystrophy protein-deficient mice represent abnormality of very long chain fatty acid metabolism. Biochem Biophys Res Commun 1997;232:631-636.
41. Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Shirayoshi Y, Mori T, Fujiki Y: A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science 1992; 255:1132-1134.
42. Dodt G, Braverman N, Wong C, Moser A, Moser HW, Watkins PA, Valle D, Gould S: Mutations in the PTS1 receptor gene, PXR1, define complementation group 1 of the peroxisome biogenesis disorders. Nat Genet 1995;9:115-125.
43. Fukuda S, Shimozawa N, Suzuki Y, Zhang Z, Tomatsu S, Tsukamoto T, Hashiguchi N, Osumi T, Masuno M, Imaizumi K, Kuroki Y, Fujiki Y, Orii T, Kondo N: Human peroxisomal assenbly factor-2 (PAF-2): A gene responsible for group C peroxisome biogenesis disorder in humans. Am J Hum Genet 1996;59: 1210-1220.
44. Chang C-C, Lee W-H, Moser HW, Valle D, Gould SJ: Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat Genet 1997;15:385-388.
45. Braverman N, Steel G, Obie C, Moser A, Moser H, Gould SJ, Valle D: Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 1997:15:369-376.
46. Motley AM, Hettema EH, Hogenhout EM, Brites P, ten Asbroek ALMA, Wijburg FO, Baas F, Heijmans HS, Tabak HF, Wanders RJA, Distel B: Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2-receptor. Nat Genet 1997;15: 377-380.
47. Purdue PE, Zhang JW, Skoneczny M, Lazarow PB: Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet 1997; 15:381-384.
48. Mosser J, Douar A-M, Sarde C-O, Kioschis P, Feil R, Moser H, Poustka A-M, Mandel J-M, Aubourg P: Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993;361:726-730.
49. Fournier B, Saudubray JM, Benichou B, Lyonnet S, Munnich A, Clevers H, Poll-The BT: Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy. J Clin Invest 1994;94:526-531.
50. Watkins PA, Chen WW, Harris CJ, Hoefler G, Hoelfer S, Blake DC Jr, Balfe A, Kelley R, Moser AB, Beard ME, et al.: Peroxisomal bifunctional enzyme deficiency. J Clin Invest 1989;83:771-777.
51. Schram AW, Goldfischer S, van Roermund CT, Brouwer-Kelder EM, Collins J, Hashimoto T, Heymans HSA, van den Bosch H, Schutgens RBH, Tager JM, et al.: Human peroxisomal 3-oxoacylcoenzyme A thiolase deficiency. Proc Natl Acad Sci USA 1987;84:2494-2496.
52. Scriver CR, Beaudet AL, Sly WS, Valle DEE: The Metabolic and Molecular Basis of Inherited Disease, ed 7. New York, McGraw-Hill, 1994, pp 2371-2383.